Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model

Novel antimicrobials for effective treatment of uncomplicated gonorrhea are essential, and the first-in-class, oral spiropyrimidinetrione DNA gyrase B inhibitor zoliflodacin appears promising. Using our newly developed Hollow Fiber Infection Model (HFIM), the pharmacodynamics of zoliflodacin was exa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Susanne Jacobsson, Daniel Golparian, Joakim Oxelbark, Francois Franceschi, David Brown, Arnold Louie, George Drusano, Magnus Unemo
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2022-04-01
Col·lecció:Frontiers in Pharmacology
Matèries:
Neisseria gonorrhoeae
hollow fiber infection model
zoliflodacin
antimicrobial treatment
pharmacodynamics
pharmacokinetics
Accés en línia:https://www.frontiersin.org/articles/10.3389/fphar.2022.874176/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars